Drugs / NAC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05509153 | Jun 2024 → Nov 2026 expected | Huntington disease | Western Sydney Local Health District | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05509153 ↗ |
| Route | Oral | “taken orally twice a day” NCT05509153 ↗ |